Publication
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): Results from a subgroup of patient from the MITO-16A-MANGO OV2A phase 4 trial.
Gennaro Daniele, Domenica Lorusso, Giovanni Scambia, Marilena Di Napoli, Maria Ornella Nicoletto, Enrico Breda, Nicoletta Colombo, Grazia Artioli, Bruno Daniele, Giovanni Lo Re, Francesco Raspagliesi, Valentina Chiappa, Vanda Salutari, Gabriella Ferrandina, Stefano Greggi, Alessandra Baldoni, Maria Carmela Piccirillo, Roldano Fossati, Francesco Perrone, Sandro Pignata
Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)
DOI: 10.1200/jco.2015.33.15_suppl.5569